The Trust Layer for Market Analysts

Rocket Lab Corporation (RKLB) has demonstrated significant market momentum, with its stock appreciating over 150% year-to-date and 466% in the last twelve months, trading at approximately $63.75 per share. Despite a reported negative profit margin of 43%, institutional investors hold a substantial 71.70% of the stock, suggesting a strong level of institutional confidence in its long-term prospects. Morgan Stanley analysts project RKLB could achieve further growth, setting a $68 price target, indicating a 5% potential upside from the current trading levels. This projection is supported by the company's comprehensive 'end-to-end' space capabilities, which include rocket launches, satellite manufacturing, software development, and mission control. Key to its future growth trajectory is the development of the Neutron rocket, a reusable medium-lift vehicle with a payload capacity of 13,000 kg to Low Earth Orbit and 1,500 kg to Mars/Venus. The Neutron is designed for mega-constellation deployments, deep space missions, and human spaceflight, representing a significant advancement over its Electron rocket, which has successfully launched 238 satellites across 72 missions. Rocket Lab's financial performance for Q2 2025 showed total revenue of $144.5 million (GAAP), reflecting a 36% year-over-year growth and 17.9% sequential growth, alongside a GAAP gross margin of 32.1%. A substantial $1 billion backlog, with 58% anticipated to convert to revenue within the next 12 months, further underpins the bullish outlook. The company's strategic initiatives, such as new launch deals and international partnerships, reinforce its market position and potential for continued expansion.